Annual Total Long Term Liabilities
$86.47 B
-$5.51 B-5.99%
31 December 2023
Summary:
AbbVie annual total long term liabilities is currently $86.47 billion, with the most recent change of -$5.51 billion (-5.99%) on 31 December 2023. During the last 3 years, it has fallen by -$22.33 billion (-20.53%). ABBV annual total long term liabilities is now -20.53% below its all-time high of $108.81 billion, reached on 31 December 2020.ABBV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$94.29 B
+$1.09 B+1.17%
30 September 2024
Summary:
AbbVie quarterly total long term liabilities is currently $94.29 billion, with the most recent change of +$1.09 billion (+1.17%) on 30 September 2024. Over the past year, it has increased by +$4.97 billion (+5.56%). ABBV quarterly long term liabilities is now -14.40% below its all-time high of $110.15 billion, reached on 30 June 2020.ABBV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.0% | +5.6% |
3 y3 years | -20.5% | -11.7% |
5 y5 years | +71.0% | +87.9% |
ABBV Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -20.5% | at low | -11.7% | +9.0% |
5 y | 5 years | -20.5% | +71.0% | -14.4% | +87.9% |
alltime | all time | -20.5% | +5076.6% | -14.4% | +6808.8% |
AbbVie Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $94.29 B(+1.2%) |
June 2024 | - | $93.20 B(-6.1%) |
Mar 2024 | - | $99.31 B(+14.8%) |
Dec 2023 | $86.47 B(-6.0%) | $86.47 B(-3.2%) |
Sept 2023 | - | $89.32 B(-1.0%) |
June 2023 | - | $90.23 B(-3.7%) |
Mar 2023 | - | $93.65 B(+1.8%) |
Dec 2022 | $91.98 B(-4.1%) | $91.98 B(-0.7%) |
Sept 2022 | - | $92.59 B(-1.5%) |
June 2022 | - | $94.03 B(-0.4%) |
Mar 2022 | - | $94.38 B(-1.6%) |
Dec 2021 | $95.90 B(-11.9%) | $95.90 B(-10.2%) |
Sept 2021 | - | $106.75 B(+0.1%) |
June 2021 | - | $106.69 B(+1.8%) |
Mar 2021 | - | $104.82 B(-3.7%) |
Dec 2020 | $108.81 B(+33.2%) | $108.81 B(-1.2%) |
Sept 2020 | - | $110.15 B(-0.0%) |
June 2020 | - | $110.15 B(+34.1%) |
Mar 2020 | - | $82.14 B(+0.5%) |
Dec 2019 | $81.70 B(+61.6%) | $81.70 B(+62.8%) |
Sept 2019 | - | $50.17 B(+2.9%) |
June 2019 | - | $48.77 B(-3.8%) |
Mar 2019 | - | $50.69 B(+0.3%) |
Dec 2018 | $50.56 B | $50.56 B(-5.8%) |
Sept 2018 | - | $53.70 B(+12.4%) |
June 2018 | - | $47.79 B(-1.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $48.73 B(-0.6%) |
Dec 2017 | $49.05 B(-5.1%) | $49.05 B(-0.1%) |
Sept 2017 | - | $49.12 B(+0.8%) |
June 2017 | - | $48.73 B(-6.0%) |
Mar 2017 | - | $51.82 B(+0.3%) |
Dec 2016 | $51.68 B(+35.3%) | $51.68 B(+1.2%) |
Sept 2016 | - | $51.05 B(-2.4%) |
June 2016 | - | $52.30 B(+36.1%) |
Mar 2016 | - | $38.41 B(+0.5%) |
Dec 2015 | $38.21 B(+165.8%) | $38.21 B(-7.2%) |
Sept 2015 | - | $41.16 B(+11.0%) |
June 2015 | - | $37.09 B(+159.9%) |
Mar 2015 | - | $14.27 B(-0.7%) |
Dec 2014 | $14.38 B(-19.3%) | $14.38 B(-16.3%) |
Sept 2014 | - | $17.17 B(-1.9%) |
June 2014 | - | $17.51 B(-1.3%) |
Mar 2014 | - | $17.74 B(-0.5%) |
Dec 2013 | $17.83 B(+5.7%) | $17.83 B(+0.2%) |
Sept 2013 | - | $17.80 B(+1.4%) |
June 2013 | - | $17.55 B(+0.6%) |
Mar 2013 | - | $17.45 B(+3.4%) |
Dec 2012 | $16.87 B(+897.0%) | $16.87 B(+896.2%) |
Sept 2012 | - | $1.69 B(+24.1%) |
June 2012 | - | $1.36 B(-2.2%) |
Mar 2012 | - | $1.40 B(-17.5%) |
Dec 2011 | $1.69 B(+1.3%) | $1.69 B |
Dec 2010 | $1.67 B | - |
FAQ
- What is AbbVie annual total long term liabilities?
- What is the all time high annual total long term liabilities for AbbVie?
- What is AbbVie annual total long term liabilities year-on-year change?
- What is AbbVie quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AbbVie?
- What is AbbVie quarterly long term liabilities year-on-year change?
What is AbbVie annual total long term liabilities?
The current annual total long term liabilities of ABBV is $86.47 B
What is the all time high annual total long term liabilities for AbbVie?
AbbVie all-time high annual total long term liabilities is $108.81 B
What is AbbVie annual total long term liabilities year-on-year change?
Over the past year, ABBV annual total long term liabilities has changed by -$5.51 B (-5.99%)
What is AbbVie quarterly total long term liabilities?
The current quarterly long term liabilities of ABBV is $94.29 B
What is the all time high quarterly long term liabilities for AbbVie?
AbbVie all-time high quarterly total long term liabilities is $110.15 B
What is AbbVie quarterly long term liabilities year-on-year change?
Over the past year, ABBV quarterly total long term liabilities has changed by +$4.97 B (+5.56%)